Neuac (Clindamycin Phosphate And Benzoyl Peroxide Gel) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 19, 2021 Category: Drugs & Pharmacology Source Type: news

clindamycin and benzoyl peroxide gel (Benzaclin, Acanya, Duac, Onexton)
Title: clindamycin and benzoyl peroxide gel (Benzaclin, Acanya, Duac, Onexton)Category: MedicationsCreated: 9/30/2001 12:00:00 AMLast Editorial Review: 3/15/2019 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - March 15, 2019 Category: Dermatology Source Type: news

Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton(R) Gel
DUBLIN, Oct. 26, 2017 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has settled the Hatch-Waxman litigation relating to Onexton® Gel (clindamycin phosphate 1.2% and benzoyl peroxide 3.75%) ... Biopharmaceuticals, Generics, Dermatology, Litigation Perrigo, Valeant Pharmaceuticals, Onexton, clindamycin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 26, 2017 Category: Pharmaceuticals Source Type: news

Neuac (Clindamycin Phosphate And Benzoyl Peroxide Gel) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 12, 2017 Category: Drugs & Pharmacology Source Type: news

Acanya Gel (Clindamycin Phosphate 1.2% and Benzoyl Peroxide 2.5%) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 3, 2017 Category: Drugs & Pharmacology Source Type: news

BenzaClin (Clindamycin and Benzoyl Peroxide) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 28, 2017 Category: Drugs & Pharmacology Source Type: news

Perrigo Announces FDA Approval and Launch of the Generic Version of BenzaClin(R) Pump Topical Gel
DUBLIN, May 2, 2016 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE: PRGO; TASE) today announced it has received final U.S. Food and Drug Administration ("FDA") approval for the generic version of Valeant Pharmaceutical In... Biopharmaceuticals, Generics, FDA, Product LaunchPerrigo, BenzaClin, Valeant Pharmaceutical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 2, 2016 Category: Pharmaceuticals Source Type: news

Clindamycin–benzoyl peroxide combo effective in moderate and severe acne
A fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% (clindamycin-BP 3.75%) aqueous gel was effective and well tolerated in the treatment of moderate and severe acne vulgaris, reported Dr. Linda Stein Gold of Henry Ford Hospital in Detroit (J Drugs Dermatol.... (Source: Skin and Allergy News)
Source: Skin and Allergy News - October 1, 2015 Category: Dermatology Source Type: news

Acne gel works better in women
A gel combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% was significantly more effective against acne vulgaris than a vehicle gel, and lesion count reductions were greater in women, based on data from a study of nearly 500 adults with moderate to severe acne. In the post hoc... (Source: Skin and Allergy News)
Source: Skin and Allergy News - April 16, 2015 Category: Dermatology Tags: FPN News FPN Dermatology IMN News IMN Dermatology OBGYN News SAN Clinical News SAN News Source Type: news

clindamycin and benzoyl peroxide gel, Benzaclin, Acanya, Duac, Onexton
Title: clindamycin and benzoyl peroxide gel, Benzaclin, Acanya, Duac, OnextonCategory: MedicationsCreated: 9/30/2001 12:00:00 AMLast Editorial Review: 4/6/2015 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - April 6, 2015 Category: Dermatology Source Type: news

Acne Doesn’t Have to Take Over Your Life
Acanya Discounts Now Available from AffordRx.com(PRWeb June 14, 2013)Read the full story at http://www.prweb.com/releases/Acanya/Discount/prweb10831947.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 16, 2013 Category: Pharmaceuticals Source Type: news